Cervical cancer is more common in younger women, with around 3,200 people diagnosed in the UK each year. It develops in the lining of the cervix – the lower part of the womb – and the main symptom is unusual or unexplained vaginal bleeding.
Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.
Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch.
Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India ‘eliminate’ cervical cancer.
We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.
New results find that the HPV vaccine was shown to dramatically reduce cervical cancer rates by 90% in women in their 20s who were offered it at age 12 to 13.
It’s completely up to you whether to go to cervical cancer screening. But the answers to these 6 questions could help you decide.
Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research
Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening.
Last year, the World Health Organisation (WHO) announced their plans to create a global strategy to accelerate the elimination of cervical cancer as a public health problem.